Bulletin
Investor Alert

Kiora Pharmaceuticals Inc.

NAS: KPRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208197856/composite

$

0.38

Change

-0.0006 -0.16%

Volume

Volume 5,716

May 20, 2022, 5:49 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208197856/composite

Previous close

$ 0.42

$ 0.38

Change

-0.04 -9.55%

Day low

Day high

$0.38

$0.43

Open
Open: 0.41

52 week low

52 week high

$0.35

$6.43

Open

Market cap

$4.85M

Average volume

288,701

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.67

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/kprx

MarketWatch News on KPRX

  1. Kiora Pharmaceuticals started at buy with $2.50 stock price target at Maxim Group

    8:58 a.m. Jan. 19, 2022

    - Tomi Kilgore

  2. EyeGate shares jump on data for eye treatment data

    9:37 a.m. Nov. 22, 2019

    - Jaimy Lee

  3. Eyegate Pharma stock surges 11% after receiving Valeant milestone payment

    8:15 a.m. May 22, 2017

    - Emma Court

  4. Valeant's stock turns up, gains 0.7% premarket after licensing deal with Eyegate Pharmaceuticals

    8:59 a.m. Feb. 21, 2017

    - Tomi Kilgore

  5. Eyegate's stock soars 52% premarket after licensing deal with Valeant

    8:59 a.m. Feb. 21, 2017

    - Tomi Kilgore

  6. Eyegate's stock soars 15% premarket after licensing deal with Valeant

    8:34 a.m. Feb. 21, 2017

    - Tomi Kilgore

  7. Valeant's stock slips 0.3% premarket

    8:34 a.m. Feb. 21, 2017

    - Tomi Kilgore

  8. Eyegate receives upfront cash payment and will received royalties as part of Valeant licensing deal

    8:33 a.m. Feb. 21, 2017

    - Tomi Kilgore

  9. Valeant enters licensing deal with EyeGate to develop treatments for eye diseases

    8:32 a.m. Feb. 21, 2017

    - Tomi Kilgore

  10. Eyegate Pharmaceuticals' stock plummets 15% after share offering

    9:36 a.m. June 27, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/kprx

Other News on KPRX

  1. 10-K: KIORA PHARMACEUTICALS INC

    9:10 a.m. April 15, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Warning: KPRX is at high risk of performing badly

    5:18 a.m. Dec. 17, 2021

    - Seeking Alpha

  3. Warning: KPRX is at high risk of performing badly

    5:46 a.m. Nov. 26, 2021

    - Seeking Alpha

  4. 10-Q: KIORA PHARMACEUTICALS INC

    8:36 a.m. Nov. 15, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. 10-Q: EYEGATE PHARMACEUTICALS INC

    4:33 p.m. Aug. 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  6. AHPI, MDIA, SCPE among mid-day movers

    12:44 p.m. Aug. 10, 2021

    - Seeking Alpha

  7. EyeGate under pressure on launch of $10.75M direct offering

    7:10 a.m. Aug. 10, 2021

    - Seeking Alpha

  8. CAN, DAO, NEGG among mid-day movers

    12:52 p.m. July 28, 2021

    - Seeking Alpha

  9. SINT, NCTY and INTZ among mid-day movers

    2:02 p.m. July 27, 2021

    - Seeking Alpha

  10. CLSK, SI and EBON among pre market gainers

    8:46 a.m. July 27, 2021

    - Seeking Alpha

  11. EyeGate names Brian Strem CEO, proposes $7M Bayon deal

    4:23 p.m. July 26, 2021

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/kprx

Press Releases on KPRX

  1. Hot Penny Stocks To Buy For Under $1 In March 2022

    1:24 p.m. March 1, 2022

    - Penny Stocks

  2. Penny Stocks For Your Biotech Watch List In September 2021

    11:05 a.m. Sept. 15, 2021

    - Penny Stocks

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.